Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population
| Status: | Completed |
|---|---|
| Conditions: | Psoriasis, Dermatology, Dermatology, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/21/2016 |
| Start Date: | June 2004 |
| End Date: | August 2005 |
An Open -Label Study to Evaluate the Effect of Pandel Cream 0.1% on the Hypothalamic Pituitary Adrenal Axis in the Pediatric and Adult Population
The purpose of this study is to determine the effect of Pandel® (hydrocortisone probutate
cream) Cream 0.1% on the Hypothalamic Pituitary Adrenal (HPA) axis in pediatric and adult
subjects with either psoriasis or atopic dermatitis involving greater than 20% body surface
area.
cream) Cream 0.1% on the Hypothalamic Pituitary Adrenal (HPA) axis in pediatric and adult
subjects with either psoriasis or atopic dermatitis involving greater than 20% body surface
area.
Inclusion Criteria:
- Clinical diagnosis of psoriasis or atopic dermatitis involving more than 20% of body
surface area
- Good health with the exception of psoriasis or atopic dermatitis
Exclusion Criteria:
- Any disease affecting the HPA-axis
- Subjects who are pregnant, nursing, or planning a pregnancy within the study
participation period
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials